Problems in dealing with missing data and informative censoring in clinical trials

Research output: Contribution to journalReview article

103 Scopus citations


A common problem in clinical trials is the missing data that occurs when patients do not complete the study and drop out without further measurements. Missing data cause the usual statistical analysis of complete or all available data to be subject to bias. There are no universally applicable methods for handling missing data. We recommend the following: (1) Report reasons for dropouts and proportions for each treatment group; (2) Conduct sensitivity analyses to encompass different scenarios of assumptions and discuss consistency or discrepancy among them; (3) Pay attention to minimize the chance of dropouts at the design stage and during trial monitoring; (4) Collect post-dropout data on the primary endpoints, if at all possible; and (5) Consider the dropout event itself an important endpoint in studies with many.

Original languageEnglish (US)
Article number4
JournalCurrent Controlled Trials in Cardiovascular Medicine
StatePublished - Jan 8 2002

All Science Journal Classification (ASJC) codes

  • Cardiology and Cardiovascular Medicine


  • Informative missing data
  • Intent to treat
  • Longitudinal study
  • Missing completely at random

Fingerprint Dive into the research topics of 'Problems in dealing with missing data and informative censoring in clinical trials'. Together they form a unique fingerprint.

  • Cite this